World Of Taxonomy
63323-886Level 3

Sodium Phosphates (sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous)

**Product type:** Human Prescription Drug

**Active ingredient:** SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

**Strength:** 142; 276 mg/mL; mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Fresenius Kabi USA, LLC

**Marketing category:** ANDA (ANDA209997)

**Pharmacologic class:** Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]

GET/api/v1/systems/ndc_fda/nodes/63323-886
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.